TODAY (12/12) reports on its website that the CDC “reports that 1 in 5 American children ages 3 through 17 – about 15 million – have a diagnosable mental, emotional or behavioral disorder in a given year.” However, just “20 percent of these children are ever diagnosed and receive treatment; 80 percent – about 12 million – aren’t receiving treatment.” The article points out that “the Child Mind Institute is collecting brain scans from 10,000 children and teens, hoping to identify biological markers of psychiatric illness.”
The Radiology Business Journal (12/11, Thakar) reports on a study published in the Journal of the American College of Radiology finding that patients who use the Internet to research breast cancer and mammography most frequently conduct searches for “mammographic efficacy (31 percent) and mammographic screening guidelines (20 percent).” They mostly found answers recommending screening, and urged radiologists to answer such questions online and to do so while identifying themselves as radiologists. The study included “more than 197,000 views of mammogram or mammography-related questions” with a focus on “51 questions and 172 responses by medical professionals and 121 questions and 172 responses by nonmedical users.”
DOT Med News (12/8, Dubinsky) reported a study published in the Journal of General Internal Medicine found that “community practices are not abiding by MR breast cancer screening guidelines.” The guidelines are supported by “the American Cancer Society, American College of Radiology and Society of Breast Imaging,” and “recommend MR exams for women who have a 20 percent or higher chance of developing breast cancer.” The study included data from the Breast Cancer Surveillance Consortium including “348,955 women in given regional BCSC regional registries who underwent mammograms and 1,499 who also received MR exams.” Overall, “about 83 percent of screening MR exams were performed on women who did not meet” the guidelines while “only a small amount of the women who met the professional guidelines received MR exams.”
The AP (12/7, Neergaard) reports on a new study launched by US health officials aiming to “tell if the newer, sometimes pricier” 3-D mammogram “really improves screening for breast cancer” compared to the traditional two-dimensional image. Researchers will recruit “165,000 women nationally to compare potentially more beneficial 3-D mammograms – known scientifically as ‘tomosynthesis’ – with standard two-dimensional digital mammography.” The study will use 100 mammography clinics across the US and in Canada to “enroll healthy women ages 45 to 74 who already are planning to get a routine mammogram” and randomly assign them to either regular or 3-D screenings for five years.
Cancer Therapy Advisor (12/6, Furlow) reports on a “review of preclinical and early human trial data” presented at the San Antonio Breast Cancer Symposium finding that “radiotherapy’s pro-immunogenic effects might improve the antitumor efficacy of immune checkpoint inhibition.” Silvia Formenti, MD, of Weill Cornell Medicine, in New York, New York, said, “Most breast cancers may require multiple immunotherapeutic interventions to become an in situ vaccine.” Dr. Formenti said that the review supports using “3 to 5 doses of 8 Gy each when radiotherapy is combined with immunotherapy.”